PJP News and Press, Invesco Dynamic Pharmaceuticals From 09/12/25

2025-09-12 01:10:00 ET By Shea Wihlborg Introduction Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. 1 While statins can reduce the risk of heart attacks by ~29%, 2 r...

2025-09-05 12:02:13 ET More on the markets: An Economy Built On Fear: Will Rate Cuts Save It? The U.S. Tariff Saga Hasn't Reached Its Climax Yet August Jobs Data Is Worse Than July Rate cuts don't stimulate growth, U.S. economy is ‘slowing slowly' ...

2025-09-05 03:30:00 ET By Frank Coughlin In the second quarter, several overarching themes emerged from earnings calls, painting a picture of a business landscape in flux. Tariffs and policy uncertainty, which were dominant themes in Q1, continue to weigh on corporate strategy.....

2025-09-02 11:15:39 ET More on The Health Care Select Sector SPDR® Fund ETF: XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? XLV: Life Expectancy, Patents, And A Positive Outlook Will Pave The Way XLV: The S&P 500's Most Discounted Sector? Uncover T...

2025-08-28 16:10:00 ET The Healthcare sector has struggled this year, driven partly by volatile U.S. tariff, research and funding policies. Jacky He, Vice President, Portfolio Research, TD Asset Management, joins MoneyTalk to discuss how investor sentiment could be changing as the secto...

2025-08-28 07:15:00 ET Manager perspective and outlook Read the full article on Seeking Alpha For further details see: Invesco Equity And Income Fund Q2 2025 Commentary

2025-08-26 10:21:33 ET More on Eli Lilly: Eli Lilly Vs. Novo Nordisk: One Stock Is Massively Undervalued, The Other Overvalued Pharmaceuticals Industry Analysis:  Eli Lilly Tops My Tier Two Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa Eli Lill...

2025-08-16 03:20:00 ET 5 Key Macro Trends 1. Trade optimism is boosting risk appetite. Progress in trade discussions between the U.S. and key trading partners has helped spark a rally in mega-cap and speculative small-cap stocks. Simultaneously, rising market confidence ...

2025-08-14 03:10:00 ET Risk aversion returned for US equity investors in August. After briefly regaining risk appetite in July, S&P Global Market Intelligence's latest Investment Manager Index survey showed a return to risk avoidance with a negative 20% reading. The index measur...

2025-08-12 05:30:00 ET After weeks of indecision, retail investors fully bought into the US stock market rally in July.... Read the full article on Seeking Alpha For further details see: Retail Investors Boost U.S. Equity Buying, Institutions Slow Stock Selling In July